Science
Mechanism of Action
This peptide is understood to function by antagonizing α-Melanocyte-stimulating hormone (α-MSH), a key precursor in melanin production. By binding to MC1R receptors located on melanocytes, it effectively blocks the hormonal signal that stimulates melanin synthesis, thereby reducing hyperpigmentation and contributing to an evening of skin tone. The incorporated palmitoyl group is believed to enhance skin permeation, facilitating its delivery to target melanocytes.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Optimal stability and efficacy are typically observed within a pH range of 5.0 to 7.0, based on insights from related peptides such as Nonapeptide-1. Comprehensive stability testing is advised for final formulations.
Safety
Safety Profile
While Palmitoyl Nonapeptide-6 was included in a broader CIR safety assessment titled 'Safety Assessment of Palmitoyl Oligopeptides', this nomenclature was later retired. A specific, standalone safety conclusion for Palmitoyl Nonapeptide-6 has not been explicitly published. No specific SCCS or FDA regulatory status was found.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Palmitoyl Nonapeptide-6 holds promise for addressing hyperpigmentation and uneven skin tone via a plausible peptide mechanism; however, specific clinical efficacy data and a standalone safety assessment remain limited, necessitating further research for definitive conclusions.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources